Very early–onset sporadic Alzheimer's disease with a de novo mutation in the PSEN1 gene

[1]  B. Tang,et al.  Mutational analysis in early-onset familial Alzheimer's disease in Mainland China , 2014, Neurobiology of Aging.

[2]  D. Dickson,et al.  Convergence of pathology in dementia with Lewy bodies and Alzheimer's disease: a role for the novel interaction of alpha-synuclein and presenilin 1 in disease. , 2014, Brain : a journal of neurology.

[3]  J. Morris,et al.  The diagnosis of dementia due to Alzheimer’s disease: Recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer's disease , 2011, Alzheimer's & Dementia.

[4]  S. Sorbi,et al.  Specific Silencing of L392V PSEN1 Mutant Allele by RNA Interference , 2011, International journal of Alzheimer's disease.

[5]  A. Singleton,et al.  Genetic screening of Alzheimer's disease genes in Iberian and African samples yields novel mutations in presenilins and APP , 2010, Neurobiology of Aging.

[6]  F. Mottaghy,et al.  A novel presenilin1 mutation (Q223R) associated with early onset Alzheimer’s disease, dysarthria and spastic paraparesis and decreased Abeta levels in CSF , 2010, European journal of neurology.

[7]  B. Bergmans,et al.  γ-secretases: from cell biology to therapeutic strategies , 2010, The Lancet Neurology.

[8]  B. Tang,et al.  A novel presenilin 1 mutation (Ser169del) in a Chinese family with early-onset Alzheimer's disease , 2010, Neuroscience Letters.

[9]  C. Duyckaerts,et al.  Biological effects of four PSEN1 gene mutations causing Alzheimer disease with spastic paraparesis and cotton wool plaques , 2006, Human mutation.

[10]  G. von Heijne,et al.  A Nine-transmembrane Domain Topology for Presenilin 1* , 2005, Journal of Biological Chemistry.

[11]  D. Campion,et al.  Molecular diagnosis of autosomal dominant early onset Alzheimer’s disease: an update , 2005, Journal of Medical Genetics.

[12]  R. Rozmahel,et al.  Dissociated phenotypes in presenilin transgenic mice define functionally distinct γ-secretases , 2005 .

[13]  F. Kametani,et al.  Longer Forms of Amyloid β Protein: Implications for the Mechanism of Intramembrane Cleavage by γ-Secretase , 2005, The Journal of Neuroscience.

[14]  J. Hardy,et al.  Presenilin 1 mutation in an african american family presenting with atypical Alzheimer dementia. , 2003, Archives of neurology.

[15]  D. Campion,et al.  Dementia with prominent frontotemporal features associated with L113P presenilin 1 mutation , 2000, Neurology.

[16]  J. Hardy,et al.  Two novel (M233T and ρ278T) presenilin‐1 mutations in early‐onset Alzheimer's disease pedigrees and preliminary evidence for association of presenilin‐1 mutations with a novel phenotype , 1997, Neuroreport.

[17]  G. Schellenberg,et al.  Secreted amyloid β–protein similar to that in the senile plaques of Alzheimer's disease is increased in vivo by the presenilin 1 and 2 and APP mutations linked to familial Alzheimer's disease , 1996, Nature Medicine.

[18]  J. Rommens,et al.  Familial Alzheimer's disease in kindreds with missense mutations in a gene on chromosome 1 related to the Alzheimer's disease type 3 gene , 1995, Nature.

[19]  G. Schellenberg,et al.  Candidate gene for the chromosome 1 familial Alzheimer's disease locus , 1995, Science.

[20]  D. Pollen,et al.  Cloning of a gene bearing missense mutations in early-onset familial Alzheimer's disease , 1995, Nature.

[21]  J. Hardy,et al.  Early-onset Alzheimer's disease caused by mutations at codon 717 of the β-amyloid precursor protein gene , 1991, Nature.

[22]  M. Pericak-Vance,et al.  Segregation of a missense mutation in the amyloid precursor protein gene with familial Alzheimer's disease , 1991, Nature.

[23]  J. Pariente,et al.  The French series of autosomal dominant early onset Alzheimer's disease cases: mutation spectrum and cerebrospinal fluid biomarkers. , 2012, Journal of Alzheimer's disease : JAD.

[24]  Jianmin Jia,et al.  One novel presenilin-1 gene mutation in a Chinese pedigree of familial Alzheimer's disease. , 2005, Journal of Alzheimer's disease : JAD.